118
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients

ORCID Icon, , & ORCID Icon
Pages 29-39 | Published online: 16 Jan 2020

References

  • Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023–1030. doi:10.1164/rccm.200510-1668OC
  • Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122(2):156–163. doi:10.1161/CIRCULATIONAHA.109.911818
  • Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351:1655–1665. doi:10.1056/NEJMra035488
  • Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. doi:10.1093/eurheartj/ehv317
  • Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30(1):104–109. doi:10.1183/09031936.00092306
  • Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161:487–492. doi:10.1164/ajrccm.161.2.9906015
  • Versari D, Daghini E, Virdis A, et al. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol. 2009;157:527–536. doi:10.1111/j.1476-5381.2009.00240.x
  • Bradley AM, Leopold JA. Emerging concepts in the molecular basis of pulmonary arterial hypertension: part II: neurohormonal signaling contributes to the pulmonary vascular and right ventricular pathophenotype of pulmonary arterial hypertension. Circulation. 2015;131:2079–2091. doi:10.1161/CIRCULATIONAHA.114.006980
  • Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J Hypertens. 2005;23(1):9–17. doi:10.1097/01.hjh.0000165623.72310.dd
  • Thenappan T, Ormiston M, Ryan J, Archer S. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:5492. doi:10.1136/bmj.j5492
  • Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2(3):286–295. doi:10.1016/j.jcmg.2008.08.007
  • Sun W, Chan SY. Pulmonary arterial stiffness: an early and pervasive driver of pulmonary arterial hypertension. Front Med. 2018;5:204. doi:10.3389/fmed.2018.00204
  • Hassoun P. Inflammation in pulmonary arterial hypertension: is it time to quell the fire? Eur Respir J. 2014;43:685–688. doi:10.1183/09031936.00006014
  • Anwar A, Ruffenach G, Mahajan A, Eghbali M, Umar S. Novel biomarkers for pulmonary arterial hypertension. Respir Res. 2016;17:88. doi:10.1186/s12931-016-0396-6
  • Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010;122:920–927. doi:10.1161/CIRCULATIONAHA.109.933762
  • Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard H, Nicolls M. Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J. 2012;40:1555–1565. doi:10.1183/09031936.00046612
  • Cracowski JL, Chabot F, Labarère J, et al. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respir J. 2014;43:915–917. doi:10.1183/09031936.00151313
  • Heresi GA, Aytekin M, Hammel JP, Wang S, Chatterjee S, Dweik R. Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension. Eur Respir J. 2014;43:912–914. doi:10.1183/09031936.00164713
  • Perros F, Dorfmuller P, Montani D, et al. Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;185:311–321. doi:10.1164/rccm.201105-0927OC
  • Stacher E, Graham BB, Hunt JM, et al. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:261–272. doi:10.1164/rccm.201201-0164OC
  • Rodríguez‐Iturbe B, Pons H, Quiroz Y, Lanaspa MA, Johnson RJ. Autoimmunity in the pathogenesis of hypertension. Nat Rev Nephrol. 2014;10:56–62. doi:10.1038/nrneph.2013.248
  • Caillon A, Schiffrin EL. Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence. Curr Hypertens Rep. 2016;18:21. doi:10.1007/s11906-016-0628-7
  • McMaster WG, Kirabo A, Madhur MS, Harrison DG. Inflammation, immunity, and hypertensive end‐organ damage. Circ Res. 2015;116:1022–1033. doi:10.1161/CIRCRESAHA.116.303697
  • Chen TH, Gona P, Sutherland PA, et al. Long‐term C‐reactive protein variability and prediction of metabolic risk. Am J Med. 2009;122:53–61. doi:10.1016/j.amjmed.2008.08.023
  • Tomiyama H, Shiina K, Matsumoto‐Nakano C, et al. The contribution of inflammation to the development of hypertension mediated by increased arterial stiffness. J Am Heart Assoc. 2017;6:e005729. doi:10.1161/JAHA.117.005729
  • Mozos I, Malainer C, Horbańczuk J, et al. Inflammatory markers for arterial stiffness in cardiovascular diseases. Front Immunol. 2017;8:1058. doi:10.3389/fimmu.2017.01058
  • Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46:1118–1122. doi:10.1161/01.HYP.0000185463.27209.b0
  • Arnold N, Gori T, Schnabel R, et al. Relation between arterial stiffness and markers of inflammation and hemostasis – data from the population-based Gutenberg health study. Sci Rep. 2017;7:6346. doi:10.1038/s41598-017-06175-2
  • Forouzan O, Dinges E, Runo JR, et al. Exercise-induced changes in pulmonary artery stiffness in pulmonary hypertension. Front Physiol. 2019;10:269. doi:10.3389/fphys.2019.00269
  • Gupta A, Sharifov O, Lloyd S, et al. Novel noninvasive assessment of pulmonary arterial stiffness using velocity transfer function. J Am Heart Assoc. 2018;7:1–28. doi:10.1161/JAHA.118.009459
  • Tan W, Madhavan K, Hunter KS, Park D, Stenmark KR. Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series). Pulm Circ. 2014;4(4):560–580. doi:10.1086/677370
  • Thenappan T, Prins K, Pritzker M, Scandurra J, Volmers K, Weir E. The critical role of pulmonary arterial compliance in pulmonary hypertension. Ann Am Thorac Soc. 2016;13(2):276–284. doi:10.1513/AnnalsATS.201509-599FR
  • Sznajder M, Dzikowska-Diduch O, Kurnicka K, et al. Increased systemic arterial stiffness in patients with chronic thromboembolic pulmonary hypertension. Cardiol J. 2018;7:e009459. doi:10.5603/CJ.a2018.0109
  • Chamorro N, Del Pozo R, García-Lucio J, et al. Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension. Eur Respir J. 2015;46:PA2452. doi:10.1183/13993003.congress-2015.PA2452
  • Alanis-Sanchez G, De La Cruz-rodriguez K, Ramos-Becerra C, et al. Association of carotid stiffness parameters with pulmonary function in patients with systemic sclerosis and pulmonary hypertension. J Hypertens. 2017;35(e–Supplement 2):e252. doi:10.1097/01.hjh.0000523735.17372.a0
  • Bergel DH. The static elastic properties of the arterial wall. J Physiol. 1961;156(3):445–457. doi:10.1113/jphysiol.1961.sp006686
  • Asmar R. Arterial Stiffness and Pulse Wave Velocity: Clinical Applications. Amsterdam, The Netherlands: Elsevier; 1999.
  • Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13:101–107. doi:10.5551/jat.13.101
  • Cheuk-Kwan S. Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness integrated. Blood Pressure Control. 2013;6:27–38. doi:10.2147/IBPC.S34423
  • Miyoshi T, Ito H. Assessment of arterial stiffness using the cardio-ankle vascular index. Pulse (Basel). 2016;4(1):11–23. doi:10.1159/000445214
  • Asmar R. Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index. Eur Heart J Suppl. 2017;19(Supplement B):B4–B10. doi:10.1093/eurheartj/suw058
  • 2018 ESC/ESH Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension. Eur Heart J. 2018;00:1–98. doi:10.1093/eurheartj/ehy339
  • Guyatt G, Sullivan M, Thompson P, et al. The 6-minute walk: a new measure of exercise capacity in subjects with chronic heart failure. Can Med Assoc J. 1985;132(919–923):PMC1345899.
  • ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six minute walk test. Am J Respir Crit Care Med. 2002;166:111–117. doi:10.1164/ajrccm.166.1.at1102
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiography. 2015;28:1–39. doi:10.1016/j.echo.2014.10.003
  • Yambe T, Yoshizawa M, Saijo Y, et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother. 2004;58(Suppl 1):S95–S98. doi:10.1016/S0753-3322(04)80015-5
  • Fukuda-Denshi Company L, Tokyo, Japan. Available from: https://fukuda.com/wp-content/uploads/2017/03/VS-1500N_Catalog_8P.pdfl.
  • Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–1327. doi:10.1016/j.jacc.2009.10.061
  • Blacher J, Guerin A, Pannier B, Marchais S, Safar M, London G. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439. doi:10.1161/01.CIR.99.18.2434
  • Safar H, Mourad -J-J, Safar M, Blacher J. Aortic pulse wave velocity, an independent marker of cardiovascular risk. Arch Mal Cœur. 2002;95:1215–1218.
  • Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15. doi:10.1161/hy0102.099031
  • Cruickshank K, Riste L, Anderson S, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106:2085–2090. doi:10.1161/01.CIR.0000033824.02722.F7
  • Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505–511. doi:10.1161/CIRCULATIONAHA.109.886655
  • Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103:987–992. doi:10.1161/01.CIR.103.7.987
  • DeLoach S, Townsend R. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol. 2008;3(1):184–192. doi:10.2215/CJN.03340807
  • Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension. 2005;45:592–596. doi:10.1161/01.HYP.0000159190.71253.c3
  • Bonarjee VVS. Arterial stiffness: a prognostic marker in coronary heart disease. Available methods and clinical application. Front Cardiovasc Med. 2018;5:64. doi:10.3389/fcvm.2018.00064
  • Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875–881. doi:10.1001/2012.jama.10503
  • Beevers G, Lip G, O’Brien E. The pathophysiology of hypertension. BMJ. 2001;322:912. doi:10.1136/bmj.322.7291.912
  • Shirai K. Analysis of vascular function using the cardio-ankle vascular index (CAVI). Hypertens Res. 2011;34:684–685. doi:10.1038/hr.2011.40
  • Obata Y, Mizogami M, Singh S, et al. The effects of hemodynamic changes on pulse wave velocity in cardiothoracic surgical patients. Biomed Res Int. 2016;2016:Article ID 9640457. doi:10.1155/2016/9640457
  • Wilenius M, Tikkakoski A, Tahvanainen A, et al. Central wave reflection is associated with peripheral arterial resistance in addition to arterial stiffness in subjects without antihypertensive medication. BMC Cardiovasc Disord. 2016;16:131. doi:10.1186/s12872-016-0303-6
  • Greene ES, Gerson JI, Arterial pulse wave velocity: a limited index of systemic vascular resistance during normotensive anesthesia in dogs. J Clin Monit. 1985;4:219–226. doi:10.1007/BF02832814
  • Ghosh A, Dharmarajan A, Swain P, Das D, Verma P, Tripathy P. Impact of cardiovascular factors on pulse wave velocity and total vascular resistance in different age group patients with cardiovascular disorders. Curr Aging Sci. 2018;11:261–268. doi:10.2174/1874609812666190226151
  • Mehta T, Nuccio E, McFann K, Madero M, Sarnak M, Jalal D. Association of uric acid with vascular stiffness in the Framingham Heart Study. Am J Hypertens. 2015;28(7):877–883. doi:10.1093/ajh/hpu253
  • Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287–1293. doi:10.1161/01.HYP.0000072820.07472.3B
  • Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13:2888–2897. doi:10.1097/01.asn.0000034910.58454.fd
  • Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood. 1997;89:577–582. doi:10.1182/blood.V89.2.577
  • Shirai K, Song M, Suzuki J, et al. Contradictory effects of beta1- and alpha1- aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI) – CAVI independent of blood pressure. J Atheroscler Thromb. 2011;18(1):49–55. doi:10.5551/jat.3582
  • Alam M, Wardell J, Andersson E, Samad BA, Nordlander R. Characteristics of mitral and tricuspid annular velocities determined by pulsed wave Doppler tissue imaging in healthy subjects. J Am Soc Echocardiogr. 1999;12:618–628. doi:10.1053/je.1999.v12.a99246
  • O M U, E E C, Ueti Ade A, de Lima-filho EC, Nogueira EA. Assessment of right ventricular function with Doppler echocardiographic indices derived from tricuspid annular motion: comparison with radionuclide angiography. Heart. 2002;88:244–248. doi:10.1136/heart.88.3.244
  • Kaul S, Tei C, Hopkins JM, Shah PM. Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J. 1984;107:526–531. doi:10.1016/0002-8703(84)90095-4
  • Forfia P, Fisher M, Mathai S, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034–1041. doi:10.1164/rccm.200604-547OC